HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Chief Counsel Has History With Sharfstein

This article was originally published in The Tan Sheet

Executive Summary

FDA named Ralph Tyler, currently Maryland's insurance commissioner, as the agency's new chief counsel

You may also be interested in...



FDA's Dickinson Named Acting Chief Counsel Following Tyler’s Departure

FDA has tapped Elizabeth Dickinson for acting chief counsel, effective Aug. 7. Dickinson is taking the post on an interim basis while the agency seeks a permanent successor to Ralph Tyler.

Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill

Ralph Tyler is leaving FDA 18 months after taking the helm as the agency's chief counsel.

CFSAN Post May Remain Unfilled Pending Food Safety Legislation Passage

Pending food safety legislation could delay FDA naming a director of the Center for Food Safety and Applied Nutrition, as the anticipated law would bring new responsibilities to the post

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136290

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel